Anzeige
Mehr »
Lynx Broker
Login
Montag, 21.10.2019 Börsentäglich über 12.000 News von 614 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A14NYH ISIN: NL0011031208 Ticker-Symbol: 6MY 
Tradegate
21.10.19
09:05  Uhr
16,300 Euro
-0,200
-1,21 %
1-Jahres-Chart
MYLAN NV Chart 1 Jahr
5-Tage-Chart
MYLAN NV 5-Tage-Chart
RealtimeGeldBriefZeit
16,300
16,700
09:46
16,300
16,700
09:46

Aktuelle News zur MYLAN Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MYLAN Aktien ab 5,80 Euro handeln - Ohne versteckte Kosten!
DiMylan working with DCGI to launch new TB drug in India15
10.10.Everolimus: Novartis stoppt TAD und Mylan: Zum 15. September ist Everofin von TAD in allen Wirkstärken ...41
02.10.Mylan (MYL) to Pay $30M to Settle SEC Charges for EpiPen6
29.09.Mylan To Invest $1 Billion In India On Capex In Six Years18
27.09.Pharma Giant Mylan To Pay $30 Million To Settle EpiPen Scandal9
27.09.Mylan to pay $30 million U.S. SEC fine related to EpiPen overcharge probe1
27.09.Mylan forks over $30M to settle SEC's EpiPen accounting probe-
27.09.Mylan to Pay $30M to Settle SEC Lawsuit Related to EpiPen Misclassification1
27.09.Mylan To Pay $30 Mln To Settle SEC Charges On EpiPen324CANONSBURG (dpa-AFX) - Mylan N.V. (MYL) agreed to pay $30 million to settle the U.S. Securities and Exchange Commission's charges against the company for accounting and disclosure failures...
► Artikel lesen
27.09.Mylan to pay $30 million to settle U.S. SEC charges over EpiPen3
27.09.Mylan to Pay $30 Million for Disclosure and Accounting Failure Relating to EpiPen332Washington, D.C.--(Newsfile Corp. - September 27, 2019) - The Securities and Exchange Commission today announced charges against Pennsylvania-based pharmaceutical company Mylan N.V. for accounting and...
► Artikel lesen
27.09.Mylan down on rumored SEC lawsuit5
27.09.U.S. SEC sues Mylan for concealing possible loss tied to EpiPen2
27.09.Mylan Sued by SEC Over Failure to Disclose Possible Loss3
20.09.Eisai's Promotion and Distribution Agreement with Mylan India for Eribulin Second Brand in India444Aiming to Expand Availability of Eribulin to Patients in India with Two Brands Halaven and TecerisTOKYO, Sept 20, 2019 - (JCN Newswire) - Eisai Co., Ltd. has announced that Eisai's subsidiary Eisai...
► Artikel lesen
09.09.Madaus: 100 Jahre Phytopharmaka: Mylan feiert das 100-jährige Jubiläum der zugehörigen Marke Madaus ...34
06.09.FiercePharmaAsia-Biocon, Mylan's Lantus copy CRL; CStone CEO pay; Novartis' site sale9
03.09.Mylan's Lantus copy derailed in U.S. again by manufacturing ills15
30.08.3 Big Stock Charts for Friday: Mylan, Newell and Home Depot10
30.08.Mylan wins tentative US approval for generic version of Lilly's Alimta - it could be years before it can be sold11
Seite:  Weiter >>
215 Nachrichten in den letzten 12 Monaten

Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
15,1,8